Millipore to Sell $550M in New Notes to Help Fund Serologicals Acquisition
Millipore said this week that it plans to raise $550 million in convertible senior notes to finance its acquisition of Serologicals.
The notes, due 2026, will be offered to institutional buyers.
Millipore said in April that it would acquire Serologicals for $1.4 billion in cash. Millipore said it will use a portion of its latest fundraising round to pay for a portion of the acquisition.